Screening for adenylosuccinate lyase deficiency: Clinical, biochemical and molecular findings in four patients
(2002) Neuropediatrics : journal of pediatric neurobiology, neurology and neurosurgery — Vol. 33, n° 4, p. 186-189 (2002)
Files
41635.pdf
Restricted Access - Adobe PDF
- 2.63 MB
Details
- Authors
- Abstract
- Adenylosuccinate lyase deficiency is an autosomal recessive defect of purine metabolism. Succinyladenosine (S-Ado) and succinylaminoimidazole carboxamide riboside (SAICAr) are the disease marker metabolites in physiological fluids. The Bratton-Marshall test for detection of SAICAr in urine has been added to the selective screening for inborn errors of metabolism that is carried out in our lab. During the last three years, around 2000 patients have been screened by this method, resulting in the detection of four new cases with this disease. They all presented with severe psychomotor delay, hypotonia and refractory epilepsy since the neonatal period. The S-Ado/SAICAr ratio in cerebrospinal fluid was below 2, indicating that they correspond to the most severe form of the disease. New missense mutations were found in a heterozygous fashion in three patients. The study of purines in all patients with neurological disease of unknown etiology is highly recommended.
- Affiliations
Citations
Castro, M., Perez-Cerda, C., Merinero, B., Garcia, M., Bernar, J., Nagel, A., Torres, J., Bermudez, M., Garavito, P., Marie, S., Vincent, F., Van den Berghe, G., & Ugarte, M. (2002). Screening for adenylosuccinate lyase deficiency: Clinical, biochemical and molecular findings in four patients. Neuropediatrics : journal of pediatric neurobiology, neurology and neurosurgery, 33(4), 186-189. https://doi.org/10.1055/s-2002-34493 (Original work published 2002)